Evaluation of Techniques for Scaling and Root Planing and One Stage Full Mouth Disinfection
Periodontal Disease, Chronic Periodontitis
About this trial
This is an interventional treatment trial for Periodontal Disease focused on measuring periodontal disease, therapy, anti-bacterial agents, Randomized Controlled Trials
Eligibility Criteria
Inclusion Criteria:
- Diagnosis of slight-moderate chronic periodontitis
Exclusion Criteria:
- Those who were making regular use of antibiotics or anti-inflammatory drugs or had done up to three months before the beginning of the study;
- those who were making regular use (twice a day) of oral rinses with chlorhexidine or essential oils or have made regular use within three months prior to study entry;
- individuals with a history of sensitivity to chlorhexidine or azithromycin;
- subjects undergoing periodontal therapy include dental scaling procedures in the 12 months preceding the start of the study;
- subjects with impaired bifurcation or trifurcation class III;
- who required antibiotic prophylaxis for conducting clinical periodontal examination
- subjects with removable partial dentures and removable or fixed orthodontic appliance.
Sites / Locations
- Douglas Campideli Fonseca
Arms of the Study
Arm 1
Arm 2
Arm 3
Arm 4
Arm 5
Arm 6
Experimental
Experimental
Experimental
Experimental
Experimental
Experimental
Full mouth disinfection - FMD
FMD + chlorhexidine (FMD-CX)
FMD + azithromycin (FMD-AZ)
Scaling and root planing (SRP)
SRP + azithromycin (SRP-AZ)
SRP + chlorhexidine (SRP-CX)
n = 10: Procedures for scaling and root planing were performed in a single stage (24 hours) divided into two sessions (60 min per session) on two consecutive days
n = 15: Same as FMD with the inclusion of chlorhexidine in office (application of chlorhexidine (CX) (1%) gel in pockets after scaling, brushing tongue for 1 min. with CX (1%) gel and mouthwash at the beginning and end of each session with CX 0.2% for 30 seconds (with the form of a gargle in the last 10 seconds)). In addition, use was made of homemade CX 0.2% for 60 days after the scaling in a single phase.
n = 15: Same as with the FMD include the use of azithromycin (500 mg) once daily for 3 consecutive days. Medication was started the same day as the end of the scaling.
(n = 13): scaling procedures were performed per quadrant (30 min. per quadrant) at weekly intervals between sessions;
n = 11: Same as scaling and root planing group (SRP) with inclusion of the use of azithromycin (500 mg) once daily for 3 consecutive days. Medication was started the same day as the end of the last scaling hemi-arch;
n = 13 : Same as group scaling and root planing (SRP) with the inclusion of home use of CX 0.2% for 60 consecutive days after the end of the first session of scaling